Abstract
Cancer immunotherapy is very effective and leads to a long-term response in certain patients. Yet, the variability observed in this response indicates that additional factors related to the host must influence the activity of the treatments. Recent research suggests that the microbiota might play an important part in this variability.
Original language | English |
---|---|
Article number | 131 |
Journal | Genome Medicine |
Volume | 7 |
Issue number | 1 |
DOIs | |
Publication status | Published - Dec 21 2015 |
ASJC Scopus subject areas
- Genetics(clinical)
- Genetics
- Molecular Biology
- Molecular Medicine